GSTM1 and secondary progressive multiple sclerosis: In a recent study of a well‐characterized cohort of 140 secondary progressive MS (SPMS) patients,16 the rate of brain atrophy significantly correlated with increased serum concentration of alpha‐Hb and beta‐Hb together with enhanced serum lactate dehydrogenase activity in SPMS patients.